pharma news today glp-1 obesity drugs What is the pipeline for future medications for obesity? GLP-1 Drug Market: the rapid
Description
For someone starting at 300 lbs, this could mean 6075 lbs lost
Without adequate protein intake and strength training, GLP-1 medications can lead to loss of lean mass along with fat
Past studies show that as much as 17% of GLP-1 users may be non-responders to the medication
In response to food intake, GIP binds to GIPR on beta cells of the pancreas, stimulating insulin secretion
In each of the two GLP-1 motifs, certain exendin-4 residues are introduced to replace the native GLP-1 residues
